HUS Comprehensive Cancer Center achieved Magnet® recognition for nursing excellence
22.3.2024 14:51:40 EET | HUS | Press release
American Nurses Credentialing Center ANCC awarded HUS Comprehensive Cancer Center the Magnet® recognition. The recognition proves that the quality of nursing, patient safety, and nurses’ job satisfaction in Comprehensive Cancer Center are measured to be excellent. Comprehensive Cancer Center is currently the second hospital in Europe and the first in the Nordic Countries to achieve Magnet recognition.
The Magnet Hospital® recognizes nursing excellence. It is a research-based quality system that benefits the patients, the nursing staff, and the entire organization. The recognition is awarded for four years at a time. The Magnet in the name represents the force that attracts patients to the hospital due to high-quality nursing and nurses due to good working environment.
“The Magnet recognition proves that the quality of nursing, patient satisfaction, and nurses’ job satisfaction are measured to be excellent in comparison with national and international results. This recognition is a wonderful prize for years of hard work,” says Vuokko Kolhonen, Chief Nursing Officer at Comprehensive Cancer Center.
“It is not a coincidence that Comprehensive Cancer Center’s nurse attraction and retention has been on a high level for years, even despite the exceptional times we’ve had in recent years. I thank our entire nursing staff for their remarkable work for the best of our patients that has now been recognized to be world-class,” says Johanna Mattson, Director of Comprehensive Cancer Center.
Proven high-quality nursing
The Magnet recognition is a framework for nursing throughout HUS. The path towards the Magnet recognition began already in 2014. Preliminary work included developing nursing culture, harmonizing practices, and collecting evidence of high-quality nursing.
The actual application process started with the submission of a preliminary application and the official application. The application had to show that nursing in Comprehensive Cancer Center meets the 50 criteria that are required for the Magnet recognition. In the final stage, ANCC’s evaluation team from the US visited the hospital to make sure that the excellent practices described in the criteria are in use throughout Comprehensive Cancer Center.
“The Magnet recognition is a major achievement for HUS. Comprehensive Cancer Center is the first department at HUS to receive the recognition. Long-term development of nursing in Comprehensive Cancer Center is a fine example to all the other departments that aim to achieve the Magnet recognition,” says Marita Ritmala, HUS Magnet Program Director.
Magnet Hospital® is a recognition awarded by the American Nurses Credentialing Center to hospitals that attract nurses and patients like a magnet. Nursing in a Magnet Hospital is measured to be of high quality, and the nurses are committed professionals who are satisfied in their work. Management is engaging and the structures that support nursing are in order.
Further information for the media:
Contacts
Marita RitmalaHUS Magnet Program Director, Nursing Administration
Tel:050 309 5518marita.ritmala@hus.fiVuokko KolhonenChief Nursing Officer, HUS, Comprehensive Cancer Center
Tel:050 427 0559vuokko.kolhonen@hus.fiAbout HUS
HUS Helsinki University Hospital is the biggest provider of specialized healthcare in Finland. Our high expertise is internationally recognized and accredited. As a university hospital, we are on the cutting edge of developing and evaluating our treatment methods and activities.
HUS treats almost 700,000 patients every year. Our nearly 27,000 professionals work to provide the best possible care for our patients. We are responsible for organizing specialized health care in the Uusimaa region. The treatment of many rare and difficult diseases in Finland has been centralized to HUS as well.
HUS – Leading healthcare
Alternative languages
Subscribe to releases from HUS
Subscribe to all the latest releases from HUS by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from HUS
Genetiska undersökningar kan avslöja orsaken till plötslig oförklarlig död hos unga14.9.2026 09:18:15 EEST | Pressmeddelande
Den bakomliggande orsaken till plötslig oförklarlig död hos unga kan vara en sällsynt ärftlig sjukdom som nödvändigtvis inte kommer fram i vanliga undersökningar. Genetiska undersökningar är en viktig del särskilt i utredningen av plötsliga oväntade dödsfall hos unga. Genetiska undersökningar kan också bidra till att identifiera släktingar som omfattas av risken och förebygga eventuella allvarliga hjärthändelser.
Geenitutkimus voi paljastaa syyn nuoren selittämättömälle äkkikuolemalle14.9.2026 09:18:15 EEST | Tiedote
Nuoren selittämättömän äkkikuoleman taustalla voi olla harvinainen perinnöllinen sairaus, joka ei välttämättä tule esiin tavanomaisissa tutkimuksissa. Geenitutkimus on tärkeä osa erityisesti nuorten odottamattomien äkkikuolemien syyn selvittämisessä. Geenitutkimus voi myös auttaa tunnistamaan riskissä olevia sukulaisia ja ehkäistä mahdollisia vakavia sydäntapahtumia.
Genetic testing may reveal the cause of sudden death in a young person14.9.2026 09:18:15 EEST | Press release
The reason for an unexplained sudden death of a young person may be a rare hereditary disease that can remain undetected in standard examinations. Genetic testing is an important part of investigating the cause of an unexpected sudden death, especially in adolescents. Genetic testing may also help to identify relatives who are at risk of sudden death, and to prevent possible severe cardiac events.
Svår RS-virusinfektion kan öka risken att barnet drabbas av astma i den tidiga barndomen8.9.2026 07:55:55 EEST | Pressmeddelande
En svår RS-virusinfektion i spädbarnsåldern ser ut att öka risken för pipande andning och astma i den tidiga barndomen. I en nyligen publicerad studie identifierades också ett nytt genområde som är förknippat med benägenheten att drabbas av RS-virusinfektion.
Vaikea RSV-infektio voi lisätä lapsen riskiä sairastua astmaan varhaislapsuudessa8.9.2026 07:55:55 EEST | Tiedote
Vauvana sairastettu vakava RSV-infektio näyttää lisäävän hengityksen vinkunan ja astman riskiä varhaislapsuudessa. Vastajulkaistussa tutkimuksessa tunnistettiin myös uusi geenialue, joka liittyy alttiuteen sairastua RSV-infektioon.
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom